Biotech Values

[DewDiligence]

Results of Generic Copaxone Survey (#msg-98954503)

There were 26 votes (excluding one vote for “No answer”).


Q: On 30-Jun-2014, which of the following is the most likely scenario?

a) FDA has approved the ANDAs from MNTA and MYL: 15%
b) FDA has approved the ANDA from MNTA only: 69%
c) FDA has approved the ANDA from MYL only: 0%
d) FDA has approved neither ANDA: 15%


Thanks to all of the participants for participating.